Biogen Inc.
BIIBFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Biogen Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 19 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 11, 2026.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-02-12 | Murphy Nicole · Head of Pharm Ops and Tech | Common Stock | P — Open market or private purchase | +3 | 195.04 | SEC filing |
| 2026-02-09 | Singhal Priya · Head of Development | Common Stock | S — Open market or private sale | −2,660 | 199.83 | SEC filing |
| 2026-02-02 | Singhal Priya · Head of Development | Common Stock | S — Open market or private sale | −748 | 179.30 | SEC filing |
| 2025-09-02 | Singhal Priya · Head of Development | Common Stock | S — Open market or private sale | −517 | 133.55 | SEC filing |
| 2025-07-08 | Izzar Rachid · Head of Global Product Strat. | Common Stock | S — Open market or private sale | −2,223 | 135.00 | SEC filing |
| 2025-05-19 | Singhal Priya · Head of Development | Common Stock | S — Open market or private sale | −3,806 | 126.25 | SEC filing |
| 2025-05-02 | DORSA CAROLINE · Director | Common Stock | P — Open market or private purchase | +1,235 | 122.72 | SEC filing |
| 2025-03-07 | SHERWIN STEPHEN A · Director | Common Stock | S — Open market or private sale | −8,760 | 150.02 | SEC filing |
Showing 8 of 10 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-09 | Pangalos Menelas N · Director | Restricted Stock Unit | M — Exercise or conversion of derivative security | −2,370 | SEC filing |
| 2026-06-09 | Pangalos Menelas N · Director | Common Stock | M — Exercise or conversion of derivative security | +2,370 | SEC filing |
| 2026-06-09 | SHERWIN STEPHEN A · Director | Common Stock | A — Grant, award, or other acquisition | +1,505 | SEC filing |
| 2026-06-09 | LANGER SUSAN · Director | Common Stock | A — Grant, award, or other acquisition | +1,505 | SEC filing |
| 2026-06-09 | Pangalos Menelas N · Director | Common Stock | A — Grant, award, or other acquisition | +1,505 | SEC filing |
| 2026-06-09 | Mantas Jesus B · Director | Common Stock | A — Grant, award, or other acquisition | +1,505 | SEC filing |
| 2026-06-09 | Patolawala Monish D · Director | Common Stock | A — Grant, award, or other acquisition | +1,505 | SEC filing |
| 2026-06-09 | HAWKINS WILLIAM A · Director | Common Stock | A — Grant, award, or other acquisition | +1,505 | SEC filing |
Showing 8 of 32 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.